# US 2023/0265408 A1 · Protease variants with improved solubility

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2023/0265408 A1
- Document ID: US20230265408A1
- Status: Published application
- Kind: A1
- Application number: 18/043,532
- Filed: 2021-08-30
- Published: 2023-08-24
- Earliest claimed: 2020-08-28
- Assignees: Novozymes A/S
- Applicants: Novozymes A/S
- Inventors: Rolf Thomas Lenhard; Esben Peter Friis; Poul Erik Pedersen; Rasmus Lund Andersen
- Web page: https://patentgrep.com/patent/US20230265408A1

## CPC

- C12N 9/16: acting on ester bonds (3.1)
- C12N 9/50: Proteinases {, e.g. Endopeptidases (3.4.21-3.4.25)}
- C08J 3/201: {Pre-melted polymers}
- C08K 11/00: Use of ingredients of unknown constitution, e.g. undefined reaction products
- C11D 3/386: Preparations containing enzymes {, e.g. protease or amylase}
- C12N 9/18: Carboxylic ester hydrolases {(3.1.1)}
- C12N 9/54: bacteria being Bacillus
- C12N 15/63: Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
- C12Y 304/21062: Subtilisin (3.4.21.62)
- C08J 2367/04: Polyesters derived from hydroxy carboxylic acids, e.g. lactones (C08J2367/06 takes precedence)
- Y02W 30/62: Plastics recycling; Rubber recycling
- C12N: MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA (microbiological testing media C12Q1/00)
- C08J: WORKING-UP; GENERAL PROCESSES OF COMPOUNDING; AFTER-TREATMENT NOT COVERED BY SUBCLASSES C08B, C08C, C08F, C08G or C08H (working, e.g. shaping, of plastics B29)
- C08K: Use of inorganic or non-macromolecular organic substances as compounding ingredients (paints, inks, varnishes, dyes, polishes, adhesives C09)
- C11D: DETERGENT COMPOSITIONS; USE OF SINGLE SUBSTANCES AS DETERGENTS; SOAP OR SOAP-MAKING; RESIN SOAPS; RECOVERY OF GLYCEROL
- C12Y: ENZYMES
- Y02W: CLIMATE CHANGE MITIGATION TECHNOLOGIES RELATED TO WASTEWATER TREATMENT OR WASTE MANAGEMENT

## Abstract

The present invention relates to protease variants, polynucleotides encoding said variants, nucleic acid constructs and expression vectors comprising said polynucleotides, host cells expressing said variants, methods of obtaining the variants, detergent compositions comprising said variants, and use of said variants or said detergent compositions.

## Claims

### Claim 1

A protease variant of a parent protease, wherein the variant has a sequence identity of at least at least 80%, but less than 100%, to SEQ ID NO:1;
wherein the variant comprises a first substitution selected from the group consisting of X215K, X215R, X215Q, X125N, X215S, and X215T;
wherein the variant comprises at least three further alterations, preferably substitutions, selected from the group consisting of X3T (e.g., S3T), X4I (e.g., V4I), X9E (e.g., S9E), I35ID, X43R (e.g., N43R), X76D (e.g., N76D), X99D (e.g., S99D, X99F (e.g., S99F), X101E (e.g., S101E), X101L (e.g., S101L), X103A (e.g., S103A), X103T (e.g., S103T), X104I (e.g., V104I), X120D (e.g., H120D), X160S (e.g., G160S), X195E (e.g., G195E), X205I (e.g., V205I), X206L (e.g., Q206L), X209W (e.g., Y209W), X235L (e.g., K235L), X259D (e.g., S259D), X261W (e.g., N261W), and X262E (e.g., L262E);
wherein the variant has protease activity; and
wherein position numbers are based on the numbering of SEQ ID NO:2.

### Claim 2 (depends on 1)

The protease variant according to claim 1, wherein the first substitution is selected from the group consisting of X215K, X215Q, X125N, X215S, and X215T; preferably the first substitution is selected from the group consisting of X215K, X215Q, X125N, and X215T.

### Claim 3 (depends on 1)

The protease variant according to claim 1, wherein the first substitution is selected from the group consisting of A215K, A215R, A215Q, A215N, A215S, and A215T; preferably the first substitution is selected from the group consisting of A215K, A215Q, A215N, A215S, and A215T; most preferably the first substitution is selected from the group consisting of A215K, A215Q, A215N, and A215T.

### Claim 4 (depends on 1)

The protease variant according to claim 1, wherein the at least three further alterations, preferably substitutions, are selected from the group consisting of S3T, V4I, S9E, I35ID, N43R, N76D, S99D, S99F, S101E, S101L, S103A, S103T, V104I, H120D, G160S, G195E, V205I, Q206L, Y209W, K235L, S259D, N261W, and L262E.

### Claim 5 (depends on 4)

The protease variant according to claim 4, wherein the at least three further alterations, preferably substitutions, are selected from one of the groups consisting of:
a) S3T, V4I, S99D, S101E, S103A, G160S, and V205I;
b) I35ID, N76D, H120D, G195E, K235L;
c) S9E, N43R, N76D, S99F, S101L, S103T, V104I, V205I, Q206L, Y209W, S259D, N261W, and L262E; and
d) S9E, N43R, N76D, V205I, Q206L, Y209W, S259D, N261W, and L262E.

### Claim 6 (depends on 1)

The protease variant according to claim 1,
which has improved solubility compared to the parent protease; preferably the solubility is improved by at least 4%, e.g., at least 10%, at least 20%, at least 30%, at least 40%, at least 50%, at least 60%, at least 70%, at least 80%, at least 90%, at least 100%, at least 125%, at least 150%, at least 175%, at least 200%, at least 250%, at least 300%, at least 400%, at least 500%, or more, compared to the parent protease

### Claim 7 (depends on 6)

The protease variant of claim 6, wherein the parent protease is an otherwise identical protease without the first substitution selected from the group consisting of X215K, X215R, X215Q, X125N, X215S, and X215T and without the at least three further alterations, preferably substitutions, selected from the group consisting of X3T (e.g., S3T), X4I (e.g., V4I), X9E (e.g., S9E), I35ID, X43R (e.g., N43R), X76D (e.g., N76D), X99D (e.g., S99D, X99F (e.g., S99F), X101E (e.g., S101E), X101L (e.g., S101L), X103A (e.g., S103A), X103T (e.g., S103T), X104I (e.g., V104I), X120D (e.g., H120D), X160S (e.g., G160S), X195E (e.g., G195E), X205I (e.g., V205I), X206L (e.g., Q206L), X209W (e.g., Y209W), X235L (e.g., K235L), X259D (e.g., S259D), X261W (e.g., N261W), and X262E (e.g., L262E).

### Claim 8 (depends on 6)

The protease variant according to claim 6, wherein the variant has improved solubility compared to SEQ ID NO:1, SEQ ID NO:3, SEQ ID NO:4, SEQ ID NO:5, and/or SEQ ID NO:6.

### Claim 9 (depends on 6)

The protease variant according to claim 6, wherein the protease variant has improved solubility at 10-30° C., preferably at 15-25° C., most preferably at 20° C.

### Claim 10 (depends on 6)

The protease variant according to claim 6, wherein the protease variant has improved solubility at pH 3-9, preferably at pH 4-8, more preferably at pH 4-6, even more preferably at pH 4-5, most preferably at pH 4.5.

### Claim 11 (depends on 6)

The protease variant according to claim 6, wherein the protease variant has improved solubility at 15-25° C. and pH 4-6, preferably at 20° C. and pH 4-5.

### Claim 12 (depends on 6)

The protease variant according to claim 6, wherein improved solubility is determined as decreased protease crystal formation and/or increased protease crystal solubility according to Example 1.

### Claim 13 (depends on 1)

The protease variant according to claim 1, which has on par or improved protease activity; preferably the protease activity is at least 100%, e.g., at least 101%, at least 102%, at least 103%, at least 104%, at least 105%, at least 110%, at least 120%, at least 130%, at least 140%, at least 150%, at least 175%, at least 200%, at least 250%, at least 300%, at least 400%, at least 500%, compared to the parent protease.

### Claim 14 (depends on 13)

The protease variant according to claim 13, wherein the parent protease is an otherwise identical protease without the first substitution selected from the group consisting of X215K, X215R, X215Q, X125N, X215S, and X215T and without the at least three further alterations, preferably substitutions, selected from the group consisting of X3T (e.g., S3T), X4I (e.g., V4I), X9E (e.g., S9E), I35ID, X43R (e.g., N43R), X76D (e.g., N76D), X99D (e.g., S99D, X99F (e.g., S99F), X101E (e.g., S101E), X101L (e.g., S101L), X103A (e.g., S103A), X103T (e.g., S103T), X104I (e.g., V104I), X120D (e.g., H120D), X160S (e.g., G160S), X195E (e.g., G195E), X205I (e.g., V205I), X206L (e.g., Q206L), X209W (e.g., Y209W), X235L (e.g., K235L), X259D (e.g., S259D), X261W (e.g., N261W), and X262E (e.g., L262E).

### Claim 15 (depends on 13)

The protease variant according to claim 13, wherein the variant has on par or improved protease activity compared to SEQ ID NO:1, SEQ ID NO:3, SEQ ID NO:4, SEQ ID NO:5, and/or SEQ ID NO:6.

### Claim 16 (depends on 1)

A polynucleotide encoding a protease variant according to claim 1.

### Claim 17 (depends on 16)

A nucleic acid construct or expression vector comprising a polynucleotide of claim 16.

### Claim 18 (depends on 1)

A host cell expressing a protease variant according to claim 1.

### Claim 19 (depends on 1)

A method for obtaining a protease variant according to claim 1, the method comprising:
(a) introducing into a parent protease a first substitution selected from the group consisting of X215K, X215R, X215Q, X125N, X215S, and X215T; and introducing at least three further alterations, preferably substitutions, selected from the group consisting of X3T (e.g., S3T), X4I (e.g., V4I), X9E (e.g., S9E), I35ID, X43R (e.g., N43R), X76D (e.g., N76D), X99D (e.g., S99D, X99F (e.g., S99F), X101E (e.g., S101E), X101L (e.g., S101L), X103A (e.g., S103A), X103T (e.g., S103T), X104I (e.g., V104I), X120D (e.g., H120D), X160S (e.g., G160S), X195E (e.g., G195E), X205I (e.g., V205I), X206L (e.g., Q206L), X209W (e.g., Y209W), X235L (e.g., K235L), X259D (e.g., S259D), X261W (e.g., N261W), and X262E (e.g., L262E); wherein the variant has protease activity; and
(b) recovering the variant.

### Claim 20 (depends on 1)

A detergent composition comprising a protease variant according to claim 1 and one or more detergent components.

### Claim 21 (depends on 20)

The detergent composition according to claim 20, wherein the composition is in the form of a bar, a homogenous tablet, a tablet having two or more layers, a pouch having one or more compartments, a regular or compact powder, a granule, a paste, a gel, or a regular, compact or concentrated liquid.

### Claim 22 (depends on 20)

The detergent composition according to claim 20, wherein the composition is in the form of a liquid.

### Claim 23

(canceled)

### Claim 24 (depends on 1)

A method of cleaning laundry or a hard surface, the method comprising contacting the laundry or hard surface with a protease variant according to claim 1.
